Fellowship · Salt Lake City, UT
Sponsored by University of Utah Health
Continued benefit of nusinersen initiated in the presymptomatic stage of spinal muscular atrophy: 5-year update of the NURTURE study.
Muscle & nerve · 2023 · 104 citations · Russell Butterfield
Effect of Different Corticosteroid Dosing Regimens on Clinical Outcomes in Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial.
JAMA · 2022 · 116 citations · Russell Butterfield
Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors.
Journal for immunotherapy of cancer · 2021 · 200 citations · Noah Kolb
Population-Based Prevalence of Myotonic Dystrophy Type 1 Using Genetic Analysis of Statewide Blood Screening Program.
Neurology · 2021 · 146 citations · Russell Butterfield
An International Perspective on Preceding Infections in Guillain-Barré Syndrome: The IGOS-1000 Cohort.
Neurology · 2022 · 75 citations · Noah Kolb
Predicting Outcome in Guillain-Barré Syndrome: International Validation of the Modified Erasmus GBS Outcome Score.
Neurology · 2022 · 61 citations · Noah Kolb
Safety and efficacy of losmapimod in facioscapulohumeral muscular dystrophy (ReDUX4): a randomised, double-blind, placebo-controlled phase 2b trial.
The Lancet. Neurology · 2024 · 34 citations · Summer Gibson
Genetic Testing to Inform Epilepsy Treatment Management From an International Study of Clinical Practice.
JAMA neurology · 2022 · 74 citations · Joshua Bonkowsky, Meghan Candee, Chris Espinoza